2019 International Congress Archives - Page 174 of 217

Self-reported substance abuse in a real-world sample of Tourette Syndrome and other tic disorder subjects

W. Deeb, A. Elkouzi, I. Malaty (Gainesville, FL, USA)
Semantic fluency impairment and amygdala atrophy are predictive factors for the development of Parkinson’s disease dementia

O. Cousins, G. Pagano, J. Schulz, G. Dervenoulas, H. Wilson, S. Caminiti, S. Polychronis, M. Politis (London, United Kingdom)
Semantic Memory Assessment in Parkinson’s Disease

J. Cardona, F. Marmolejo-Ramos, C. Trujillo, M. Larson (Santiago de Cali, Colombia)
Sensitivity of magnetic resonance imaging findings in the diagnosis of progressive supranuclear palsy

L. Marques, V. Silva, J. Araújo, S. Varanda, G. Carneiro, M. Rodrigues (Braga, Portugal)
Sequencing of single human nigral dopaminergic neurons for somatic copy number variants

D. Perez-Rodriguez, M. Kalyva, S. Santucci, K. Mokretar, M. Leija-Salazar, A. Schapira, T. Lashley, J. Holton, C. Proukakis (London, United Kingdom)
Serological analysis of circulating Alpha Synuclein protein levels by Surface Plasmon Resonance (SPR) In Parkinson’s disease

A. Singh, T. Bajaj, A. Dey, S. Dey (New Delhi, India)
Serotonergic function in De Novo Parkinson’s Disease

HK. Park, JJ. Lee, YM. Park (Goyang, Republic of Korea)
Serum Inflammatory Profile for the Discrimination of tremor severity in essential tremor

Z. Muruzheva, D. Traktirov, I. Ivleva, V. Maystrenko, M. Karpenko (Saint-Petersburg, Russian Federation)
Serum MIR-96-5P and MIR-339-5P as a Potential Biomarker for Multiple System Atrophy and Parkinson’s Disease

A. Vallelunga, T. Iannitti, S. Capece, G. Somma, G. Dati, P. Barone, W. Meissner, M. Pellecchia (Salerno, Italy)
Serum mucosal chemokine levels in patients with Parkinson disease.

S. Haji, W. Sako, N. Murakami, Y. Osaki, Y. Izumi (Tokushima, Japan)